drugset / Trial / NCT01200602

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

NCT01200602

RandomizedParallel-groupOpen-labelSupportive care

Summary

RATIONALE: Megestrol acetate may help improve appetite and lessen weight loss caused by cancer. PURPOSE: This clinical trial studies megestrol acetate in treating weight loss or anorexia in young patients with malignancies who are undergoing radiation therapy and/or chemotherapy.

Timeline

Start
2011-03
Primary completion
2011-11
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified 5 mg/kg Oral
Subject Megestrol Acetate Other / unclassified 10 mg/kg Oral

Indications